Similar articles

• A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.

  [No authors listed] [No authors listed] AIDS. 1998 Oct 1;12(14):F151-60. AIDS. 1998. PMID: 9792371 Clinical Trial.
• A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.

  Henry K, Erice A, Tierney C, Balfour HH Jr, Fischl MA, Kmack A, Liou SH, Kenton A, Hirsch MS, Phair J, Martinez A, Kahn JO. Henry K, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):339-49. doi: 10.1097/00042560-199812010-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9833742 Clinical Trial.
• An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.

  [No authors listed] [No authors listed] AIDS. 1999 Apr 1;13(5):565-73. AIDS. 1999. PMID: 10203381 Clinical Trial.
• [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].

  Aguirrebengoa K, Mallolas J, Uriz J, Torres Tortosa M. Aguirrebengoa K, et al. Enferm Infecc Microbiol Clin. 1996 Oct;14 Suppl 1:3-9. Enferm Infecc Microbiol Clin. 1996. PMID: 9053024 Review. Spanish. No abstract available.
• Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.

  Matthews SJ, Cersosimo RJ, Spivack ML. Matthews SJ, et al. Pharmacotherapy. 1991;11(6):419-48; discussion 448-9. Pharmacotherapy. 1991. PMID: 1722897 Review.